Literature DB >> 8793551

Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis.

C H Evans1, P D Robbins, S C Ghivizzani, J H Herndon, R Kang, A B Bahnson, J A Barranger, E M Elders, S Gay, M M Tomaino, M C Wasko, S C Watkins, T L Whiteside, J C Glorioso, M T Lotze, T M Wright.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8793551     DOI： 10.1089/hum.1996.7.10-1261

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  48 in total

Review 1.  Cytokine-based immunointervention in the treatment of autoimmune diseases.

Authors:  L Adorini
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

Review 2.  Gene targeting: roadmap to future therapies.

Authors:  Lars C Huber; Thomas Pap; Ulf Müller-Ladner; Renate E Gay; Steffen Gay
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

Review 3.  Gene therapy for rheumatoid arthritis.

Authors:  P D Robbins; C H Evans; Y Chernajovsky
Journal:  Springer Semin Immunopathol       Date:  1998

4.  Gene therapy in autoimmune diseases.

Authors:  C H Evans; J D Whalen; C H Evans; S C Ghivizzani; P D Robbins
Journal:  Ann Rheum Dis       Date:  1998-03       Impact factor: 19.103

Review 5.  Gene therapy for rheumatoid arthritis. Theoretical considerations.

Authors:  Y Chernajovsky; A Annenkov; C Herman; K Triantaphyllopoulos; D Gould; H Dreja; S P Moyes; J L Croxford; R A Mageed; O L Podhajcer; D Baker
Journal:  Drugs Aging       Date:  1998-01       Impact factor: 3.923

Review 6.  Prospects for gene therapy in sports medicine.

Authors:  T G Gerich; F H Fu; P D Robbins; C H Evans
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  1996       Impact factor: 4.342

Review 7.  A gene therapy approach to treatment of autoimmune disease.

Authors:  C M Seroogy; C G Fathman
Journal:  Immunol Res       Date:  1998-08       Impact factor: 2.829

Review 8.  Current status of gene therapy for rheumatoid arthritis.

Authors:  Daniel F Gaddy; Paul D Robbins
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

9.  Clinical responses to gene therapy in joints of two subjects with rheumatoid arthritis.

Authors:  Peter Wehling; Julio Reinecke; Axel W A Baltzer; Markus Granrath; Klaus P Schulitz; Carl Schultz; Rüdiger Krauspe; Theresa W Whiteside; Elaine Elder; Steven C Ghivizzani; Paul D Robbins; Christopher H Evans
Journal:  Hum Gene Ther       Date:  2009-02       Impact factor: 5.695

Review 10.  Gene therapy of the rheumatic diseases: 1998 to 2008.

Authors:  Christopher H Evans; Steven C Ghivizzani; Paul D Robbins
Journal:  Arthritis Res Ther       Date:  2009-01-30       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.